This inventor holds 2 USPTO granted patents and 4 published patent applications. Top assignee: Emendobio Inc.. Active years: 2023-2025.
Company Filing History:
Years Active: 2023-2025
Title: Innovations of Nadav Marbach-Bar
Introduction
Nadav Marbach-Bar is a prominent inventor based in Rehovot, Israel. He has made significant contributions to the field of genetic engineering, particularly in the development of methods to address genetic mutations.
Latest Patents
Nadav holds two patents, showcasing his innovative approach to genetic research. His latest patents include a method to inactivate a mutant allele of the ELANE gene, which is associated with severe congenital neutropenia (SCN) and cyclic neutropenia (CyN). This method utilizes CRISPR nuclease technology to target and inactivate the mutant allele effectively. Additionally, he has developed a non-naturally occurring composition comprising a CRISPR nuclease with a high degree of sequence identity to a specific amino acid sequence, further advancing the capabilities of gene editing.
Career Highlights
Nadav is currently associated with Emendobio Inc., where he continues to push the boundaries of genetic research. His work has garnered attention for its potential applications in treating genetic disorders.
Collaborations
Nadav collaborates with notable colleagues, including David Baram and Lior Izhar, who contribute to his innovative projects and research endeavors.
Conclusion
Nadav Marbach-Bar's contributions to genetic engineering through his patents and work at Emendobio Inc. highlight his role as a leading inventor in the field. His innovative methods have the potential to significantly impact the treatment of genetic conditions.